[UPDATED JULY 18]
The exciting news was announced last week that pre-exposure prophylaxis has been shown to work for heterosexual men and women as well as MSM. This is HUGE for HIV prevention.
Below is a selection of news items and press releases we have collected on the two studies that reported out last week. In the comments feel free to share your reactions to this news.
Washington Post: Two studies show that drugs used to treat AIDS can be used to prevent HIV infection, too
EurekAlert (Microbicide Trials Network): VOICE study will continue as it considers what action to take after results of 2 trials
CDC: CDC Trial and Another Major Study Find PrEP Can Reduce Risk of HIV Infection among Heterosexuals
iPrEX News: Two Major Studies Prove HIV Pre-Exposure Prophylaxis (PrEP) Works in Heterosexual Women and Men; Build on iPrEx Data Showing PrEP Reduces HIV Infections in Men Who Have Sex with Men
Wall Street Journal: AIDS Drugs Can Prevent Infection, Studies Show
AIDSMAP: Two major studies show that HIV drugs prevent infection
New Vision: Drugs prevent HIV infection up to 73%
Science Now: Anti-HIV Pills Show Powerful Effect Against AIDS
Reuters: 2-Once-daily AIDS pill can slash HIV infection risk
POZ: PrEP Reduces HIV Risk in Two Major Studies
PlusNews: HIV/AIDS: More proof that PrEP works
New Scientist: One cheap pill protects healthy people from HIV
The Daily Nation: Daily dose of drug ‘lowers risk of HIV infection’
Fit Perez: New Pill Could Prevent HIV
Project Inform: Project Inform urges government action following the positive results of two PrEP studies in heterosexual men and women
[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]